Showing results (1541-1550 of 1,662) with videos related to

Sort By:
Pageof 167
Elife|March 25, 2024
Fetal liver macrophages contribute to the hematopoietic stem cell niche by controlling granulopoiesisAmir Hossein Kayvanjoo, Iva Splichalova, David Alejandro Bejarano, et al.
Health Technology Assessment (Winchester, England)|September 11, 2024
Chair-based yoga programme for older adults with multimorbidity: RCT with embedded economic and process evaluationsGarry Alan Tew, Laura Wiley, Lesley Ward, et al.
Biorxiv : the Preprint Server for Biology|August 16, 2024
Deciphering tumour microenvironment and elucidating the origin of cancer cells in ovarian clear cell carcinomaUma S Kamaraj, Pradeep Gautam, Terence Cheng, et al.
Antimicrobial Agents and Chemotherapy|May 23, 2002
Identification of a series of tricyclic natural products as potent broad-spectrum inhibitors of metallo-beta-lactamasesDavid J Payne, Juan Antonio Hueso-Rodríguez, Helen Boyd, et al.
BMC Cancer|March 2, 2019
Primary paediatric epidural sarcomas: molecular exploration of three casesSharon Y Y Low, Chik Hong Kuick, Wan Yi Seow, et al.
Proceedings of the National Academy of Sciences of the United States of America|May 9, 2008
Platinum-based inhibitors of amyloid-beta as therapeutic agents for Alzheimer's diseaseKevin J Barnham, Vijaya B Kenche, Giuseppe D Ciccotosto, et al.
Clinical Chemistry|May 14, 2026
Exploring Sex-Specific High-Sensitivity Cardiac Troponin Thresholds for Rule-Out of Non-ST-Elevation Myocardial InfarctionIngar Ziad Restan, Yong Yong Tew, Ole-Thomas Steiro, et al.
Gynecologic Oncology|March 23, 2025
Patient outcomes in advanced ovarian cancer treated with an anti-FOLR1 antibody-drug conjugatePaul Johannet, Matthew Flint, M Herman Chui, et al.
Gynecologic Oncology|January 2, 2021
Exploring the clinical significance of serous tubal intraepithelial carcinoma associated with advanced high-grade serous ovarian cancer: A Memorial Sloan Kettering Team Ovary StudyThomas Boerner, Henry S Walch, Bastien Nguyen, et al.
The American Journal of Gastroenterology|October 16, 2013
EMerging BiomARKers in Inflammatory Bowel Disease (EMBARK) study identifies fecal calprotectin, serum MMP9, and serum IL-22 as a novel combination of biomarkers for Crohn's disease activity: role of cross-sectional imagingWilliam A Faubion, Joel G Fletcher, Sharon O'Byrne, et al.
Pageof 167